The 6 most recent market catalysts affecting $TCRT, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 18, 2026
Corporate Catalyst
Bullish
Impact 75
TCRT stock has given up its prior gain. Alaunos Therapeutics shares were trading higher after the company filed a patent application for "Identification Of Neoantigen-Reactive T Cell Receptors"
This headline highlights a common scenario in biotechnology: initial excitement over a scientific breakthrough or patent filing often gives way to a more sober assessment of its lo…
Sep 18, 2026
Corporate Catalyst
Bullish
Impact 75
Alaunos Therapeutics shares are trading higher after the company filed a patent application for "Identification Of Neoantigen-Reactive T Cell Receptors"
The patent application for 'Identification Of Neoantigen-Reactive T Cell Receptors' is a significant corporate catalyst for Alaunos Therapeutics (TCRT). This intellectual property …
Sep 18, 2026
Corporate Catalyst
Neutral
Impact 55
Alaunos Therapeutics Announces $1.12M Direct Offering Of 380,469 Shares And Warrants To Purchase Up To 386,654 Shares At $1.46 Per Share
Alaunos Therapeutics (TCRT) has announced a direct offering of 380,469 shares and warrants to purchase an additional 386,654 shares, priced at $1.46 per share, aiming to raise $1.1…
Sep 18, 2026
Corporate Catalyst
Neutral
Impact 65
Alaunos Therapeutics On Thursday Filed Patent Application "Identification Of Neoantigen-Reactive T Cell Receptors"
Alaunos Therapeutics (TCRT) has filed a patent application titled 'Identification Of Neoantigen-Reactive T Cell Receptors.' This patent aims to protect methods for identifying spec…
Sep 18, 2026
Corporate Catalyst
Bullish
Impact 55
Why Alaunos Therapeutics Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
Alaunos Therapeutics (TCRT) filed an 8-K announcing the immediate adoption of its Second Amended and Restated By-Laws. While this is a corporate governance update, often considered…
Sep 18, 2026
Corporate Catalyst
Bullish
Impact 65
Alaunos Therapeutics (TCRT) Stock Soars Over 29% After-Hours: Here's What's Going On
Alaunos Therapeutics (TCRT) approved and adopted new bylaws, effective immediately, which significantly lower the quorum required for shareholder meetings from a majority to one-th…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.